CORTICOTROPIN (corticotropin) by Teva is clinical pharmacology purified cortrophin gel is the anterior pituitary hormone which stimulates the functioning adrenal cortex to produce and secrete adrenocortical hormones. Approved for infantile spasms, epilepsy. First approved in 1957.
Drug data last refreshed 19h ago · AI intelligence enriched 1w ago
Corticotropin is a purified anterior pituitary hormone administered by intramuscular injection that stimulates the adrenal cortex to produce and secrete adrenocortical hormones. It is indicated for infantile spasms and epilepsy, with peak cortisol effects observed 8 hours post-injection. The drug has been in use since 1957 and represents a unique endocrine mechanism distinct from modern anticonvulsants.
This product is in late-stage lifecycle with moderate competitive pressure (30/100), indicating a transitional commercial phase where teams are optimizing existing market share rather than driving expansion.
CLINICAL PHARMACOLOGY Purified Cortrophin Gel is the anterior pituitary hormone which stimulates the functioning adrenal cortex to produce and secrete adrenocortical hormones. Following administration of a single intramuscular injection of 80 Units of Cortrophin Gel to healthy volunteers (n=20) in…
Worked on CORTICOTROPIN at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Dose Response Relationship for Single Doses of Corticotropin Releasing Hormone (CRH) in Normal Volunteers and in Patients With Adrenal Insufficiency
Corticotropin supports a very lean team with only 1 linked job opening, primarily in research roles, reflecting its niche market status and mature commercial phase. Career progression on this product is limited; professionals should expect stable but non-growth opportunities focused on market maintenance and regulatory compliance.
1 open roles linked to this drug